3 high-quality ASX 200 shares to buy forever

Analysts think these strong shares are top buys right now.

| More on:
Business women working from home with stock market chart showing per cent change on her laptop screen.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best ways to grow your wealth is arguably to invest in high quality companies with a long-term view.

The latter gives your investment time to compound and supercharge your returns and wealth creation.

As for the former, they say the cream always rises to the top. And this is usually the case in the share market with the very best companies delivering the best returns over the long term.

But which ASX 200 shares could be classed as high quality? Let's look at three that could be buys according to analysts. They are as follows:

CSL Limited (ASX: CSL)

CSL could be one of the highest quality companies on the ASX boards. It is one of the world's leading biotechnology companies with a collection of businesses that are leaders in the respective fields. This includes CSL Behring, CSL Vifor, and Seqirus businesses, which focus on blood plasma products, kidney therapies, and vaccines, respectively.

But CSL is never one to rest on its laurels. Each year it reinvests in the region of 12% back into its research and development activities. This ensures that it has a pipeline of potentially lucrative treatments.

Macquarie is a big fan of the company sees scope for its shares to rise to $500 in the coming years. But in the immediate term, the broker has an outperform rating and $330.00 price target on them.

Goodman Group (ASX: GMG)

A second high quality ASX 200 share for investors to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a world class portfolio of assets in key locations across the globe.

Strong demand for these assets has underpinned stellar earnings growth over the last decade. The good news is that Morgan Stanley thinks this positive form can continue. Especially given its belief that Goodman's exposure to artificial intelligence through its data centre pipeline will be another driver of future growth.

Morgan Stanley currently has an overweight rating and $36.65 price target on its shares.

ResMed Inc. (ASX: RMD)

Bell Potter thinks that this sleep disorder treatment company could be a high quality ASX 200 share to buy.

The broker likes ResMed due to its significant opportunity as a leader in obstructive sleep apnoea (OSA) and other sleep disorders. It notes that "the market for OSA and chronic obstructive pulmonary disease (COPD) remains under penetrated, and we expect industry volume growth to continue in the 6-8% range for the foreseeable future."

This bodes well for its sales and earnings growth over the next decade. Particularly given that one of its key rivals has been battling a major product recall.

Bell Potter has a buy rating and $36.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goodman Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Broker Notes

Why did this top broker just downgrade DroneShield shares?

The broker believes its shares are fully valued at current levels.

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
Broker Notes

Woolworths shares 'less placed' says top broker

Could the supermarket giant's share price be under pressure?

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

The Australian share market is expected to return to form today.

Read more »

Man on a laptop thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield-eque start to the trading week this Monday.

Read more »

A young boy with a sombre face looks down at the zip fastener at the bottom of his jacket as he concentrates on unfastening the clasp.
BNPL shares

What's happening with Zip shares on their first day back aboard the ASX 200?

After a strong eight month run, Zip shares are once again part of the ASX 200.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Healthcare Shares

If you invested $5,000 in this ASX pharmaceuticals stock a year ago, you'd have $34,711 now!

Just how lucky have investors been with this stock?

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Share Gainers

Why these 2 ASX 200 shares are surging amid today's market meltdown

Investors are bidding up these two ASX 200 shares despite the wider market meltdown. But why?

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why 29Metals, Immutep, Insignia, and Perenti shares are pushing higher today

These shares are avoiding the market selloff. But why?

Read more »